276 related articles for article (PubMed ID: 12470434)
1. The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.
White JD
J Altern Complement Med; 2002 Oct; 8(5):545-50. PubMed ID: 12470434
[TBL] [Abstract][Full Text] [Related]
2. Complementary and alternative medicine research: a National Cancer Institute perspective.
White JD
Semin Oncol; 2002 Dec; 29(6):546-51. PubMed ID: 12516037
[TBL] [Abstract][Full Text] [Related]
3. Blending the boundaries: steps toward an integration of complementary and alternative medicine into mainstream practice.
Giordano J; Boatwright D; Stapleton S; Huff L
J Altern Complement Med; 2002 Dec; 8(6):897-906. PubMed ID: 12614540
[TBL] [Abstract][Full Text] [Related]
4. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine.
Kantor M
J Am Coll Radiol; 2009 Apr; 6(4):254-62. PubMed ID: 19327658
[TBL] [Abstract][Full Text] [Related]
5. Complementary and alternative therapeutics: rigorous research is needed to support claims.
Kinsel JF; Straus SE
Annu Rev Pharmacol Toxicol; 2003; 43():463-84. PubMed ID: 12540748
[TBL] [Abstract][Full Text] [Related]
6. The CAM Education Program of the National Center for Complementary and Alternative Medicine: an overview.
Pearson NJ; Chesney MA
Acad Med; 2007 Oct; 82(10):921-6. PubMed ID: 17895649
[TBL] [Abstract][Full Text] [Related]
7. Use of complementary medicine by adult patients participating in cancer clinical trials.
Sparber A; Bauer L; Curt G; Eisenberg D; Levin T; Parks S; Steinberg SM; Wootton J
Oncol Nurs Forum; 2000 May; 27(4):623-30. PubMed ID: 10833691
[TBL] [Abstract][Full Text] [Related]
8. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
9. Research on complementary and alternative medicine using randomized controlled trials.
Harlan WR
J Altern Complement Med; 2001; 7 Suppl 1():S45-52. PubMed ID: 11822635
[TBL] [Abstract][Full Text] [Related]
10. Complementary and alternative medicine. Considering the alternatives.
Weber DO
Physician Exec; 1998; 24(6):6-14. PubMed ID: 10351720
[TBL] [Abstract][Full Text] [Related]
11. New opportunities and proven approaches in complementary and alternative medicine research at the National Institutes of Health.
Harlan WR
J Altern Complement Med; 2001; 7 Suppl 1():S53-9. PubMed ID: 11822636
[TBL] [Abstract][Full Text] [Related]
12. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
13. Surveys of complementary and alternative medicine: Part II. Use of alternative and complementary cancer therapies.
Sparber A; Wootton JC
J Altern Complement Med; 2001 Jun; 7(3):281-7. PubMed ID: 11439851
[TBL] [Abstract][Full Text] [Related]
14. Complementary and alternative medicine: opportunities and challenges for cancer management and research.
Richardson MA; Straus SE
Semin Oncol; 2002 Dec; 29(6):531-45. PubMed ID: 12516036
[TBL] [Abstract][Full Text] [Related]
15. Rationales for CAM Education in Health Professions Training Programs.
Gaylord SA; Mann JD
Acad Med; 2007 Oct; 82(10):927-33. PubMed ID: 17895650
[TBL] [Abstract][Full Text] [Related]
16. State of the center, CAM use in cancer patients, and initiatives with the FDA are topics of 14th NACCAM meeting.
Le Tourneau M
Altern Ther Health Med; 2003; 9(4):18. PubMed ID: 12868248
[No Abstract] [Full Text] [Related]
17. Integrating complementary and alternative medicine instruction into health professions education: organizational and instructional strategies.
Lee MY; Benn R; Wimsatt L; Cornman J; Hedgecock J; Gerik S; Zeller J; Kreitzer MJ; Allweiss P; Finklestein C; Haramati A
Acad Med; 2007 Oct; 82(10):939-45. PubMed ID: 17895652
[TBL] [Abstract][Full Text] [Related]
18. Translational research in cancer complementary and alternative medicine: the National Cancer Institute's Best Case Series Program.
Lee CO
Clin J Oncol Nurs; 2004 Apr; 8(2):212-4. PubMed ID: 15108425
[TBL] [Abstract][Full Text] [Related]
19. National Cancer Institute's OCCAM partners with NCCAM to expand research on unconventional cancer treatments.
Muscat M
Altern Ther Health Med; 1999 Jul; 5(4):26-30. PubMed ID: 10394671
[No Abstract] [Full Text] [Related]
20. Bridging CAM practice and research: teaching CAM practitioners about research methodology.
Zick SM; Benn R
Altern Ther Health Med; 2004; 10(3):50-6. PubMed ID: 15154153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
